Family Practice NewsTech-based cancer company raises access concernsOctober 12, 2018Practice ManagementOncologyHematologyBusiness of Medicine
Family Practice NewsCrizanlizumab relieves sickle cell crises across subgroupsOctober 11, 2018Hematology
The Journal of Family PracticeWhat’s the best VTE treatment for patients with cancer?October 1, 2018OncologyHematology
The Journal of Family PracticeStrategies for caring for the well cancer survivorOctober 1, 2018OncologyHematology
Family Practice NewsAntithrombotic strategy 1 year after stenting in AF patients leans toward oral anticoagulant aloneSeptember 28, 2018CardiologyHematology
Family Practice NewsCoagulopathy outbreak underscores danger of synthetic cannabinoidsSeptember 26, 2018Addiction MedicineHematology
Family Practice NewsRivaroxaban bonus: Early unmasking of occult GI cancersSeptember 22, 2018CardiologyGastroenterologyHematology
Family Practice NewsHormonal contraceptive use linked to leukemia risk in offspringSeptember 11, 2018PediatricsWomen's HealthOncologyContraceptionHematology
Family Practice NewsEmicizumab beats factor VIII prophylaxis by a wide marginAugust 30, 2018Hematology
Family Practice NewsCervical cancer screening recommendations vary by age and riskAugust 21, 2018Women's HealthOncologyHematology
Family Practice NewsIntegrated pain program reduced LOS for sickle cell patientsAugust 21, 2018HematologyPediatrics
Family Practice NewsGroups release guidelines for CAR T treatment in childrenAugust 10, 2018PediatricsHematologyOncology
